Manfred Rüdiger, Ariceum Therapeutics CEO
June 2, 2023 07:20 AM EDT
Deals

Ger­man ra­dio­phar­ma biotech ac­quires British start­up in tiny deal

Max Gelman

Senior Editor

Two pri­vate biotechs pulled off a small merg­er on Thurs­day.

Berlin-based Ariceum Ther­a­peu­tics ac­quired the UK’s Ther­ag­nos­tics, the com­pa­nies an­nounced, for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Chi­na’s biotech mar­ket is stag­ing a come­back that US biotech can on­ly wish for

Large vac­cine mak­ers stand by their in­vest­ments de­spite US head­winds

With aims to be­come a 'gen­er­a­tional biotech,' Zealand Phar­ma hires Lil­ly vet­er­an as sci­ence chief

Genen­tech vet launch­es ADC start­up with $20M

Makary, in one of first com­ments on FDA pol­i­cy, floats new path­way for rare dis­ease drugs

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times